Disc Medicine · 3 months ago
Vice President, Clinical Pharmacology, Pharmacometrics and DMPK
Disc Medicine is a clinical-stage biopharmaceutical company focused on developing novel treatments for serious hematologic diseases. The Vice President of Clinical Pharmacology, Pharmacometrics and DMPK will lead the integration of these functions into the R&D strategy and drive critical development and regulatory decisions across the pipeline.
BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Responsibilities
Further establish and lead the Clinical Pharmacology, Pharmacometrics and DMPK function. Define strategic vision, operational frameworks, and best practices tailored to Disc Medicine’s portfolio and R&D goals
Lead the clinical pharmacology and DMPK on cross-functional R&D teams, contributing to nonclinical and clinical development plans, study protocols, and decision-making at all stages
Apply quantitative methodologies—including population PK/PD, exposure–response modeling, PBPK, and QSP—to inform dose selection, clinical trial design, special population strategies, and regulatory submissions
Drive the clinical pharmacology and DMPK strategy for INDs, CTAs, NDAs/BLAs. Oversee related authorship and review of key regulatory documents and engagement with global health authorities
Collaborate closely with Clinical Development, Regulatory Affairs, CMC, Innovation, Toxicology, and Biomarker teams to ensure alignment and integration of Clinical Pharmacology and DMPK throughout R&D
Maintain expertise in evolving clinical pharmacology and pharmacometrics, and DMPK approaches. Represent Disc Medicine in external scientific forums, regulatory meetings, and industry collaborations
Qualification
Required
PhD or PharmD in Clinical Pharmacology, DMPK, Pharmaceutical Sciences, or a related scientific discipline
20+ years of relevant industry experience, including 10+ years in a leadership capacity within clinical pharmacology and/or DMPK
Track record of supporting research and development programs including leading Clinical pharmacology/DMPK in regulatory filings and successful interactions with global health authorities
Expertise in a broad range of Clinical Pharmacology and DMPK areas with comprehensive understand of the applications of modeling and simulation methodologies (e.g., popPK, PBPK, exposure–response, QSP)
Demonstrated ability to work collaboratively in a cross-functional, matrixed environment and to influence at all levels of the organization
Excellent communication skills, including the ability to distill complex scientific analyses into clear, actionable recommendations
Benefits
Comprehensive benefits
Competitive compensation packages
Company
Disc Medicine
Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.
Funding
Current Stage
Public CompanyTotal Funding
$1.29BKey Investors
Hercules CapitalFrazier Life SciencesBain Capital Life Sciences
2025-10-21Post Ipo Secondary· $25M
2025-10-21Post Ipo Equity· $225M
2025-01-22Post Ipo Equity· $225.5M
Recent News
2026-01-17
2026-01-16
Company data provided by crunchbase